Champions Oncology, Inc. (CSBR)
The company now
Champions Oncology, Inc. is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836), based in Baltimore, MD. In its latest annual figures on file, for the fiscal year ended 2026-04-30, it reported revenue of $59 million and a loss of $1.2 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
Where the revenue comes from
fiscal 2026, as filedRevenue by product, fiscal 2026
| Product | Fiscal 2026 | Fiscal 2025 | Share of revenue |
|---|---|---|---|
| Pharmacology Services | $57.1M | $48.6M | 96.1% |
| Product and Service Other | $1.5M | $3.7M | 2.6% |
| Translational Oncology Solutions TOS License Revenue | $764,000 | $4.7M | 1.3% |
As tagged in its annual report (Form 10-K, filed Jul 27, 2026 ↗), read from the SEC's financial statement data sets. The year before is the figure the record holds for the prior fiscal year.
The desk's written account of this company, its Past, Present and Future, is not on file yet.
How the company works
The desk has not read this company's annual report yet.
The record in brief
The desk has not written this company's report yet.